Premature Rupture of Membranes (PROM) Testing Market

Premature Rupture of Membranes (PROM) Testing: Introduction

• Premature rupture of membranes (PROM) is defined as the rupture of gestational membranes (breakage of the amniotic sac) prior to the onset of labor. When membrane breakage occurs before 37 weeks of gestation, it is referred to as preterm (PROM). In PROM, the rupture of fetal membrane occurs at least one hour prior to the onset of labor, at less than equal to 37 weeks gestation. It occurs in 10% to 15% of term pregnancies, and is associated with minimal risk to the mother and fetus due to the advanced gestation. Preterm premature rupture of membranes (PPROM) occurs at more than 37 weeks gestation. It is associated with 40% preterm deliveries. The fetal membrane consists of the chorion and amnion. Infection, genetic predisposition, and early activation of the physiological process rupture the membrane. Painless popping sensations and watery fluid leaking from the vagina is a symptom of PROM. Diagnosis is usually done based on maternal history of membrane rupture and other tests.

Key Drivers and Restraints of Premature Rupture of Membranes (PROM) Testing Market

• Rise in Prevalence of Preterm Births
  • Rise in prevalence of pre- and post-natal complications, increase in investment in medical research by health care companies, surge in prevalence of preterm births, preference to less invasive surgeries, and undesirable consequences connected with the use of traditional diagnostic procedures drive the global premature rupture of membranes market.
  • In the U.S., premature rupture of membranes testing is used to measure the level of chemical known to exist in amniotic fluid, but not in vaginal fluid. The global premature rupture of membranes testing market is likely to be driven by an increase in the number of preterm birth cases.
  • Hence, rise in prevalence of preterm births and increase in demand for premature rupture of membranes testing are projected to boost the growth of the global premature rupture of membranes testing market

Premature Rupture of Membranes (PROM) Testing Market: Segmentation

• In terms of type, the global premature rupture of membrane (PROM) testing market can be classified into nitrazine/pH test, ferning test, amnisure test, and others
• In terms of end-user, the global premature rupture of membranes (PROM) testing market can be divided into hospitals, clinics, diagnostic laboratories, and others

Europe Premature Rupture of Membranes (PROM) Testing Market to Grow at a Rapid Pace

• In terms of region, the global premature rupture of membranes testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
• Europe is anticipated to dominate the global premature rupture of membranes testing market during the forecast period due to rise in prevalence of preterm births. Growth of the pharmaceutical market due to early-phase diagnosis & surgery for preterm diseases and high death rate are expected to drive the premature rupture of membranes testing market in Europe.
• North America was the second largest market for premature rupture of membranes testing in 2020 due to favorable government policies for health care infrastructure and increase in the number of preterm births. According to the Centers for Disease Control and Prevention, in 2019, 1 in 10 babies was born preterm in the U.S.
• Technologically advanced test kits, increase in penetration of testing procedures, availability of advanced testing, and high per capita spending is likely to fuel the growth of the premature rupture of membranes testing market in Asia Pacific.
• Economic growth in countries such as India and China in Asia Pacific and Brazil in Latin America has aided the development of health care infrastructure in these regions. This presents significant opportunities in the premature rupture of membranes testing market in these regions during the forecast period.

Leading Players Operating in Global Premature Rupture of Membranes (PROM) Testing Market

Key players operating in the global premature rupture of membrane (PROM) testing market are:

• Abbott Laboratories
• Cooper Surgical
• Sera Prognostics
• QIAGEN
• Parsagen Diagnostics, Inc.
• Medix Biochemica
• IQ Products
• Hologic
• Biosynex
• NX Prenatal
• Laboratorios Rubio
• Clinical Innovations
• Others

Global Premature Rupture of Membranes (PROM) Testing Market: Research Scope

Global Premature Rupture of Membranes (PROM) Testing Market, by Type

• Nitrazine/pH Test
• Ferning Test
• Amnisure Test
• Others

Global Premature Rupture of Membranes (PROM) Testing Market, by End-user

• Hospitals
• Clinics
• Diagnostic Laboratories
• Others

Global Premature Rupture of Membranes (PROM) Testing Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa